Treatment for diabetic macular oedema:looking further into the evidence

作     者：Noemi Lois 

作者机构：Wellcome-Wolfson Centre for Experimental MedicineSchool of MedicineDentistry and Biomedical SciencesQueen’s UniversityBelfastUK 

出 版 物：《Annals of Eye Science》 (眼科学年鉴（英文）)

年 卷 期：2018年第3卷第1期

页      面：7-13页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：Diabetic macular edema(DME) diabetic macular oedema(DMO) anti-vascular endothelial growth factor(anti-VEGF) laser photocoagulation randomised clinical trials(RCTs) retina diabetic retinopathy 

摘      要：Throughout the years,people with diabetic macular oedema(DMO)have seen the number of options for their treatment *** photocoagulation was the first of these and great experience is behind it;intraocular steroids followed and more recently anti-vascular endothelial growth factor(anti-VEGF)agents came to *** face now the dilemma of determining which may be the best therapeutic strategy for each particular patient based on best available *** article summarises data available from randomised clinical trials(RCTs)on treatments for DMO and provides some facts about this condition and its treatments that need to be taken into consideration when treatment decisions are made.